KarynAGoodmanMD

Radiation Oncology • New York, NY

Professor and Associate Director of Clinical Research, The Tisch Cancer Institute at Mount Sinai

Join to view full profile

Dr. Goodman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Goodman's full profile

Already have an account?

Office
The Tisch Cancer Institute at Mount Sinai
One Gustave L Levy Place
New York, NY 10029
Phone+1 212-241-0385

Education & Training

Memorial Sloan Kettering Cancer CenterResidency, Radiation Oncology, 2000 - 2004
Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1999 - 2002
Stanford University School of MedicineClass of 1999

Certifications & Licensure

NY State Medical License 2000 - 2025
CO State Medical License 2015 - 2021
CA State Medical License 2004 - 2010
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

Top Doctors: New York Metro Area Castle Connolly, 2014

Clinical Trials

Combination Chemotherapy and Bevacizumab With or Without Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Start of enrollment: 2007 Mar 01
Completed
Not Applicable
Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer Start of enrollment: 2008 Jun 01
Completed
Phase 3
S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct Start of enrollment: 2008 Dec 01
Completed
Phase 2
Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery Start of enrollment: 2010 Apr 05
Active, not recruiting
Phase 3
Phase II Gemcitabine + Fractionated Stereotactic Radiotherapy for Unresectable Pancreatic Adenocarcinoma Start of enrollment: 2009 Oct 01
Completed
Phase 2
PET Scan Imaging in Assessing Response in Patients With Esophageal Cancer Receiving Combination Chemotherapy Start of enrollment: 2011 Jul 01
Completed
Phase 2
Dose Escalation Trial of Endoluminal High-Dose-Rate Brachytherapy With Concurrent Chemotherapy for Rectal or Anal Cancer in Patients With Recurrent Disease or Undergoing Non-Operative Management Start of enrollment: 2014 Jul 01
Active, not recruiting
Phase 1
Join now to see all

Publications & Presentations

PubMed

Reply: Letter to the Editor of Annals Surgical Oncology Concerning "Updates on the Version 9 American Joint Committee on Cancer Staging System for Anal Cancer." Is the...
Lauren M Janczewski, Elliot A Asare, Karyn A Goodman
Annals of Surgical Oncology. 2024-12-09
NRG Oncology International Consensus Contouring Atlas on Target Volumes and Dosing Strategies for Dose-Escalated Pancreatic Cancer Radiotherapy.
Nina N Sanford, Amol K Narang, Todd A Aguilera, Michael F Bassetti, Michael D Chuong
International Journal of Radiation Oncology, Biology, Physics. 2024-11-05
Recapping Radiation Related Abstracts at ASCO 2024: A Commentary about the Fundamental Role of Radiation Therapy in Esophageal and Lung Cancers.
Salma K Jabbour, Kristin A Higgins, Sue S Yom, Karyn A Goodman
International Journal of Radiation Oncology, Biology, Physics. 2024-10-01

Lectures

Survival outcomes from CALGB 80803 (Alliance): A randomized phase II trial of PET scan-directed combined modality therapy for esophageal cancer.
2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018

Press Mentions

Anal Cancer in the United States Linked to AIDS and InequalitiesMarch 17th, 2023
Radiotherapy Improves Survival in Difficult Liver Cancer CasesOctober 31st, 2022
Eng Named Co-Chair of NCI Clinical Trials Steering CommitteeSeptember 23rd, 2021
Join now to see all

Professional Memberships

American Society of Clinical Oncology - ASCO
Member